Free Trial

Matinas Biopharma (MTNB) SEC Filings & 10K Form

Matinas Biopharma logo
$0.60 +0.01 (+1.71%)
As of 04/24/2025 03:59 PM Eastern

Recent Matinas Biopharma SEC Filings

DateFilerForm TypeView
04/22/2025
4:28 PM
Matinas Biopharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
04/15/2025
4:18 PM
Matinas Biopharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/10/2025
8:39 PM
Matinas Biopharma (Issuer)
STERN ADAM K (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/10/2025
4:14 PM
Matinas Biopharma (Subject)
Sanitam Partners LLC (Filed by)
Form SCHEDULE 13D/A
04/10/2025
3:45 PM
Matinas Biopharma (Issuer)
Sanitam Partners LLC (Reporting)
Form 4/A
04/10/2025
12:54 PM
Matinas Biopharma (Issuer)
Pembroke & Partners LLC (Reporting)
Form 4/A
04/10/2025
12:59 PM
EIDE ROBERT J (Reporting)
Matinas Biopharma (Issuer)
Form 4/A
04/10/2025
12:44 PM
Matinas Biopharma (Subject)
Pembroke & Partners LLC (Filed by)
Form SCHEDULE 13D/A
04/08/2025
4:25 PM
Matinas Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2025
4:15 PM
Matinas Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2025
4:15 PM
Matinas Biopharma (Filer)
Form NT 10-K
03/17/2025
4:30 PM
Matinas Biopharma (Issuer)
NEUGEBOREN EDWARD (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/17/2025
4:30 PM
Matinas Biopharma (Issuer)
Murphy Keith (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/14/2025
4:20 PM
Matinas Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2025
6:01 AM
Matinas Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2025
5:35 PM
EIDE ROBERT J (Reporting)
Matinas Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/03/2025
4:25 PM
Matinas Biopharma (Filer)
Form DEF 14A
02/28/2025
3:58 PM
Matinas Biopharma (Issuer)
Sanitam Partners LLC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/25/2025
5:35 PM
Matinas Biopharma (Issuer)
Pembroke & Partners LLC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/21/2025
4:15 PM
Matinas Biopharma (Filer)
Form PRE 14A
02/21/2025
2:07 PM
Matinas Biopharma (Subject)
Sanitam Partners LLC (Filed by)
Form SCHEDULE 13D
02/21/2025
2:11 PM
Matinas Biopharma (Subject)
Pembroke & Partners LLC (Filed by)
Form SCHEDULE 13D
02/19/2025
3:05 PM
Matinas Biopharma (Filer)
Form D
Notice of Exempt Offering of Securities 
02/19/2025
1:22 PM
111 Equity Group (Filed by)
Matinas Biopharma (Subject)
Form SCHEDULE 13D/A
02/13/2025
5:00 PM
Matinas Biopharma (Issuer)
Smith Robin L (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/13/2025
4:20 PM
Matinas Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2025
4:00 PM
D An Evelyn (Reporting)
Matinas Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/07/2025
6:30 AM
Matinas Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2025
4:15 PM
Matinas Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
4:15 PM
Matinas Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
4:16 PM
Matinas Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2024
5:31 AM
Matinas Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2024
8:15 AM
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
Matinas Biopharma (Subject)
Form SC 13G
09/03/2024
7:56 AM
Matinas Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2024
8:39 PM
Matinas Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
3:06 PM
Matinas Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:MTNB) was last updated on 4/25/2025 by MarketBeat.com Staff
From Our Partners